Two Sigma Investments’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.47M | Sell |
60,844
-119,305
| -66% | -$8.76M | 0.01% | 1254 |
|
|
2025
Q1 | $20.6M | Sell |
180,149
-22,379
| -11% | -$2.56M | 0.04% | 466 |
|
|
2024
Q4 | $10.2M | Sell |
202,528
-153,522
| -43% | -$7.74M | 0.02% | 703 |
|
|
2024
Q3 | $16.5M | Sell |
356,050
-37,730
| -10% | -$1.75M | 0.04% | 533 |
|
|
2024
Q2 | $12.8M | Sell |
393,780
-424,695
| -52% | -$13.8M | 0.03% | 579 |
|
|
2024
Q1 | $20.6M | Buy |
818,475
+340,918
| +71% | +$8.59M | 0.05% | 406 |
|
|
2023
Q4 | $15.5M | Buy |
477,557
+222,292
| +87% | +$7.22M | 0.04% | 465 |
|
|
2023
Q3 | $6.95M | Buy |
255,265
+80,721
| +46% | +$2.2M | 0.02% | 701 |
|
|
2023
Q2 | $3.88M | Buy |
+174,544
| New | +$3.88M | 0.01% | 986 |
|
|
2020
Q2 | – | Sell |
-10,554
| Closed | -$125K | – | 2036 |
|
|
2020
Q1 | $125K | Buy |
+10,554
| New | +$125K | ﹤0.01% | 1699 |
|
|
2019
Q2 | – | Sell |
-18,597
| Closed | -$218K | – | 2113 |
|
|
2019
Q1 | $218K | Buy |
+18,597
| New | +$218K | ﹤0.01% | 1910 |
|
|
2018
Q1 | – | Sell |
-133,732
| Closed | -$2.42M | – | 2024 |
|
|
2017
Q4 | $2.42M | Sell |
133,732
-233,167
| -64% | -$4.21M | 0.01% | 1066 |
|
|
2017
Q3 | $7.08M | Buy |
366,899
+189,573
| +107% | +$3.66M | 0.03% | 569 |
|
|
2017
Q2 | $2.09M | Sell |
177,326
-5,603
| -3% | -$66.1K | 0.01% | 1044 |
|
|
2017
Q1 | $2.01M | Sell |
182,929
-429,871
| -70% | -$4.71M | 0.01% | 1158 |
|
|
2016
Q4 | $4.45M | Buy |
612,800
+393,999
| +180% | +$2.86M | 0.02% | 751 |
|
|
2016
Q3 | $1.42M | Buy |
218,801
+26,069
| +14% | +$169K | 0.01% | 1180 |
|
|
2016
Q2 | $1.05M | Buy |
192,732
+49,474
| +35% | +$270K | ﹤0.01% | 1285 |
|
|
2016
Q1 | $670K | Sell |
143,258
-96,575
| -40% | -$452K | ﹤0.01% | 1465 |
|
|
2015
Q4 | $1.19M | Buy |
239,833
+24,636
| +11% | +$123K | 0.01% | 1171 |
|
|
2015
Q3 | $809K | Buy |
215,197
+53,558
| +33% | +$201K | ﹤0.01% | 1100 |
|
|
2015
Q2 | $971K | Buy |
+161,639
| New | +$971K | ﹤0.01% | 1423 |
|